How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

764 results for

Menorrhagia Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Naturopathic Medicine for the Management of Endometriosis, Dysmenorrhea, and Menorrhagia: A Content Analysis. (PubMed)

Naturopathic Medicine for the Management of Endometriosis, Dysmenorrhea, and Menorrhagia: A Content Analysis. To explore the recommendations of naturopathic medicine for the management of endometriosis, dysmenorrhea, and menorrhagia, drawing on traditional and contemporary sources.Content analysis.Australia, Canada, and the United States of America (USA).Contemporary sources were identified from reviewing naturopathic higher education institutions' recommended texts, while traditional sources (...) , and chemical-based medicines. Herbal medicines were extensively reported from all sources for the management of endometriosis, dysmenorrhea, and menorrhagia. Clinical nutrition was only recommended from contemporary sources for all three conditions. Mineral medicines were mentioned in both traditional and contemporary sources, but were only recommended for dysmenorrhea and menorrhagia. There were limited recommendations for homeopathy and hydrotherapy treatments in all conditions across all sources

Full Text available with Trip Pro

2018 Journal of Alternative and Complementary Medicine

2. Menorrhagia Management

Menorrhagia Management Menorrhagia Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Menorrhagia Management Menorrhagia (...) Management Aka: Menorrhagia Management , Ovulatory Bleeding Management From Related Chapters II. Management: General Suppress and Endometrial Thickening 10 mg PO daily on days 5-26 of cycle (21 days per month) Avoid only (10 day) - low efficacy Combination 1 tab orally daily Reduce blood loss by 50% in women with heavy Conventional 28 day cycling High High Low Natazia (Estradiol + Dienogest) First FDA approved specifically for (2012) However, expensive and does not offer any additional benefit over

2018 FP Notebook

3. Effectiveness of bipolar impedance controlled radiofrequency (NovaSure) endometrial ablation for the treatment of menorrhagia in Hong Kong Chinese women (PubMed)

% at 24 and 36 months of follow up. Endometritis occurred in 9.7%. No case required blood transfusion or other surgical management post-operatively. Improvement in all aspects of MIQ was seen when compared post-operative scores to preoperative scores (p < 0.01). 100% claimed improvement in menstruation and 87.1% suggested they would recommend the procedure to family and friends.Bipolar impedance controlled radiofrequency endometrial ablation appears to be an effective method for managing menorrhagia (...) Effectiveness of bipolar impedance controlled radiofrequency (NovaSure) endometrial ablation for the treatment of menorrhagia in Hong Kong Chinese women Bipolar impedance controlled radiofrequency endometrial ablation is a valuable treatment options for menorrhagia. We examined the short term outcomes of Hong Kong Chinese women undergone this procedure.All patients who underwent this procedure at Queen Elizabeth Hospital, Hong Kong during January 2013 to August 2016. Method

Full Text available with Trip Pro

2017 Gynecology and Minimally Invasive Therapy

4. Bleeding versus Clotting: A Complex Case of a Large Fibroid Uterus Causing Menorrhagia and a DVT (PubMed)

Bleeding versus Clotting: A Complex Case of a Large Fibroid Uterus Causing Menorrhagia and a DVT A 43-year-old woman presented with severe anaemia secondary to menorrhagia. Pelvic ultrasound showed a large intramural posterior fundal fibroid. Hysteroscopy showed the fibroid distorting the endometrial cavity, precluding Mirena® device insertion. As she was initially hesitant to have a hysterectomy, medical management with the oral contraceptive pill (OCP) and tranexamic acid was instituted (...) to a total abdominal hysterectomy. Mass effect from large uterine fibroids can cause venous thromboembolism (VTE). A duplex ultrasound of the lower limbs if a woman presents with a large fibroid could identify asymptomatic DVTs in such women. A prehysterectomy IVC filter would then reduce their risk of postoperative pulmonary embolism. Medical management of menorrhagia with procoagulants should be avoided for management of menorrhagia in such women given their higher risk of developing VTE.

Full Text available with Trip Pro

2016 Case reports in obstetrics and gynecology

5. Incidental finding of a huge ovarian serous cystadenoma in an adolescent female with menorrhagia (PubMed)

Incidental finding of a huge ovarian serous cystadenoma in an adolescent female with menorrhagia Pelvic tumors in adolescent females are very uncommon. While the most common presentation is pelvic discomfort, we report the case of a 14-year-old female presenting with menorrhagia which is an unusual initial complaint for a large pelvic tumor. Adolescent females who present with heavy menstrual bleeding initially undergo assessment to rule out a bleeding disorder. In this case, careful history (...) and physical examination helped in making a quick diagnosis and management. Ultrasound of abdomen showed a huge cystic mass due to serous cystadenoma of the ovary.

Full Text available with Trip Pro

2016 SAGE Open Medical Case Reports

6. Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity

Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02685501 Recruitment Status : Unknown Verified February 2016 by Shoshana Vilk, Hadassah Medical Organization. Recruitment

2016 Clinical Trials

7. Heavy menstrual bleeding: assessment and management

Update information 30 Heavy menstrual bleeding: assessment and management (NG88) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 3 of 36This guideline replaces CG44. This guideline is the basis of QS47. Ov Overview erview This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman's (...) Heavy menstrual bleeding: assessment and management Hea Heavy menstrual bleeding: assessment vy menstrual bleeding: assessment and management and management NICE guideline Published: 14 March 2018 nice.org.uk/guidance/ng88 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

8. Diagnosis and management of gonorrhoea and syphilis

Diagnosis and management of gonorrhoea and syphilis 2019 www.kce.fgov.be KCE REPORT 310 DIAGNOSIS AND MANAGEMENT OF GONORRHOEA AND SYPHILIS 2019 www.kce.fgov.be KCE REPORT 310 GOOD CLINICAL PRACTICE DIAGNOSIS AND MANAGEMENT OF GONORRHOEA AND SYPHILIS VICKY JESPERS, SABINE STORDEUR, ANJA DESOMER, SERENA CARVILLE, CLARE JONES, SEDINA LEWIS, MARK PERRY, SAM CORDYN, TINE CORNELISSEN, TANIA CRUCITTI, CELINE DANHIER, IRITH DE BAETSELIER, ANNE-SOPHIE DE CANNIÈRE, WOUTER DHAEZE, ELS DUFRAIMONT, CHRIS (...) KENYON, AGNES LIBOIS, SAPHIA MOKRANE, ELIZAVETA PADALKO, SANDRA VAN DEN EYNDE, WIM VANDEN BERGHE, THIERRY VAN DER SCHUEREN, NICOLE DEKKER COLOPHON Title: Diagnosis and management of gonorrhoea and syphilis Authors: Vicky Jespers (KCE), Sabine Stordeur (KCE), Anja Desomer (KCE), Serena Carville (NGC), Clare Jones (NGC), Sedina Lewis (NGC), Mark Perry (NGC), Sam Cordyn (Wit-Gele Kruis van Vlaanderen), Tine Cornelissen (Domus Medica), Tania Crucitti (Institute of Tropical Medicine(ITM)), Céline Danhier

2019 Belgian Health Care Knowledge Centre

9. Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders

menorrhagia is consistently reported to be 10% to 20% and is even higher in adolescents presenting with menorrhagia. Options Diagnostic tools and specific medical and, where appropriate, surgical alternatives to management are reviewed and evidence-based recommendations presented. Evidence A MEDLINE search of the English literature between January 1975 and November 2003 was performed using the following key words: menorrhagia, uterine bleeding, pregnancy, von Willebrand, congenital bleeding disorder (...) Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders No. 163-Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 2, Pages e91–e103 No. 163-Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders x Christine Demers , MD Québec City, QC x Christine Derzko , MD Toronto, ON x

2018 Society of Obstetricians and Gynaecologists of Canada

10. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update)

United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update) United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update) Guideline development group: Jonathan Ross (lead author), Michelle Cole, Ceri Evans, Deirdre Lyons, Gillian Dean, Darren Cousins, PPI representative What is new in the 2019 interim update? • the European Medicines Agency has released new guidance highlighting the potential for disabling (...) principles needed for the effective management of pelvic inflammatory disease (PID) covering the management of the initial presentation, as well as how to reduce transmission, complications and future repeat infection. It is aimed primarily at women aged 16 years or older (see specific guidelines for those under 16) presenting to health care professionals working in departments offering specialist care in STI management within the United Kingdom. However, the principles of the recommendations should

2019 British Association for Sexual Health and HIV

11. British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae

British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae 1 British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019) Helen Fifer, John Saunders, Suneeta Soni, S Tariq Sadiq, Mark FitzGerald British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018) Suneeta Soni, Paddy Horner, Michael (...) genital reconstructive surgery • Recommendations for extra-genital testing in those with suspected or confirmed antimicrobial resistance • Epidemiological treatment is recommended only for those presenting within 14 days of exposure. For those presenting after 14 days of exposure we recommend treatment based on the results of testing 3 SCOPE AND PURPOSE This guideline offers recommendations for the diagnostic tests, treatment regimens and health promotion principles needed for the effective management

2019 British Association for Sexual Health and HIV

12. 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease

2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease 2 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease Guideline development group: Jonathan Ross (lead author), Michelle Cole, Ceri Evans, Deirdre Lyons, Gillian Dean, Darren Cousins, PPI representative What is new in the 2018 update? ? the role of Mycoplasma genitalium (...) suggested as empirical treatment for male partners of women with PID to reduce exposure to macrolide antibiotics which has been associated with increased resistance in M. genitalium ? references have been updated ? the Grade system for reporting strength of evidence has been adopted 3 Introduction and methodology Objectives This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of pelvic inflammatory disease

2018 British Association for Sexual Health and HIV

13. Radiologic Management of Uterine Leiomyomas

Radiologic Management of Uterine Leiomyomas Revised 2017 ACR Appropriateness Criteria ® 1 Radiologic Management of Uterine Leiomyomas American College of Radiology ACR Appropriateness Criteria ® Radiologic Management of Uterine Leiomyomas Variant 1: Middle-aged woman with multiple uterine fibroids resulting in a 20-week-sized uterus on physical examination and menorrhagia. Bulk symptoms of urinary frequency and bloating are present. The patient has a recent negative serum pregnancy test and has (...) with menorrhagia and pelvic pain. Most of the fibroids measure 6 cm. Uterus is 12 cm on MRI. The patient states that she does not desire future pregnancies and is concerned about the loss of femininity with hysterectomy. Procedure Appropriateness Category Medical management Usually Not Appropriate MR-guided high-frequency focused ultrasound ablation Usually Not Appropriate Endometrial ablation Usually Not Appropriate Uterine artery embolization Usually Appropriate Laparoscopic uterine artery occlusion Usually

2017 American College of Radiology

14. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association

Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February (...) 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 Free Access article Share on Jump to Free Access article Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association , RN, MN, FAHA, Chair , MD, FRCP, Co-Chair , MD , MD , MD , MD, DPhil , MD, FAHA, FRCPC , MD , and MD, FRCPC MD, FAHAOn behalf of the American Heart Association Council

Full Text available with Trip Pro

2017 American Heart Association

15. Menorrhagia Management

Menorrhagia Management Menorrhagia Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Menorrhagia Management Menorrhagia (...) Management Aka: Menorrhagia Management , Ovulatory Bleeding Management From Related Chapters II. Management: General Suppress and Endometrial Thickening 10 mg PO daily on days 5-26 of cycle (21 days per month) Avoid only (10 day) - low efficacy Combination 1 tab orally daily Reduce blood loss by 50% in women with heavy Conventional 28 day cycling High High Low Natazia (Estradiol + Dienogest) First FDA approved specifically for (2012) However, expensive and does not offer any additional benefit over

2015 FP Notebook

16. Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease

Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Minimize Menorrhagia (...) : Margaret Ragni Collaborators: University of North Carolina Duke University Information provided by (Responsible Party): Margaret Ragni, University of Pittsburgh Study Details Study Description Go to Brief Summary: This is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize menorrhagia in women with type 1 von Willebrand disease (VWD). The purpose of this Phase III multicenter

2015 Clinical Trials

17. Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02616731 Recruitment Status : Unknown Verified November 2015 by Ahmed Alanwar, Ain Shams University. Recruitment status was: Recruiting

2015 Clinical Trials

18. Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia

Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) current. The goal of this study is to compare these two energies, by measuring the amount of bleeding calculated by the Higham score 12 months after the intervention. Condition or disease Intervention/treatment Phase Menorrhagia Procedure: Monopolar current Procedure: Bipolar current Not Applicable Detailed Description: Menorrhagia are one of the main symptoms that are managed in Gynecology. The evaluation of the volume of menorrhagia is performed by a PBAC score (pictorial bleeding assesment chart

2015 Clinical Trials

19. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis. (PubMed)

favored LNG-IUS over conventional medical treatment, although use of various measurements limited our ability to pool the data for more powerful evidence. Serious adverse events were statistically comparable between treatments.The LNG-IUS was the more effective first choice for management of menorrhagia compared with conventional medical treatment. Long-term, randomized trials are required to further investigate patient-based outcomes and evaluate the cost-effectiveness of the LNG-IUS and other (...) Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis. The aim of this study was to compare the effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) with conventional medical treatment in reducing heavy menstrual bleeding.Relevant studies were identified by a search of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and clinical trials registries (from inception to April 2014). Randomized

Full Text available with Trip Pro

2014 Medical science monitor : international medical journal of experimental and clinical research

20. Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding

Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding NatioNal CerviCal SCreeNiNg Program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding eNdorSed by Short form Summary of reCommeNdatioNS2 CerviCal SCreeNiNg guideliNeS © Cancer Council australia date published: June 2016 this work is copyright. apart from any (...) preference in each individual case. the guidelines are designed to provide information to assist in decision-making. the guidelines are not meant to be prescriptive. Conflict of interest the development of the National Cervical Screening Program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding has been undertaken by a non-remunerated Cervical Cancer Screening guidelines Working Party. observers/non-voting

2016 Cancer Council Australia

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>